Metoprolol Orion (Metoprolol Succinate)

Metoprolol succinate selectively blocks β1‑adrenergic receptors in the heart. This inhibition reduces heart rate, myocardial contractility, and cardiac output, which together lower arterial pressure and myocardial oxygen demand, helping control high blood pressure and chest‑pain episodes.

The appropriate dose of Metoprolol Orion is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for metoprolol succinate during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment options with their healthcare provider.

To request Metoprolol Orion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Metoprolol is a cardio‑selective beta‑blocker, whereas other antihypertensive classes such as ACE inhibitors, ARBs, calcium‑channel blockers, and diuretics act through different mechanisms. Beta‑blockers primarily reduce heart rate and contractility, making them especially useful in patients with concomitant angina or heart‑failure, while other classes may be preferred when beta‑blocker–related side effects are a concern.

Metoprolol Orion should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Metoprolol Orion is taken orally, usually once daily due to its extended‑release formulation. It should be swallowed whole with a glass of water and not crushed, chewed, or split, unless specifically instructed by a healthcare professional.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and worsening heart‑failure symptoms. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling of the ankles, or difficulty breathing.

Metoprolol Orion is contraindicated in individuals with known hypersensitivity to metoprolol or any component of the formulation, those with severe sinus bradycardia, second‑ or third‑degree AV block without a pacemaker, and patients in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe chronic obstructive pulmonary disease.